Full-Time

Associate Director

Regional Marketer, Northwest Region

Posted on 5/14/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

201-500 employees

Develops therapies for central nervous system disorders

Biotechnology
Healthcare

Compensation Overview

$160k - $190kAnnually

+ Bonus + Equity

Senior, Expert

Washington, USA + 6 more

More locations: Kansas, USA | North Dakota, USA | Oregon, USA | Montana, USA | South Dakota, USA | Colorado, USA

Field-based position in the Northwest region; candidates must live in WA, OR, MT, CO, ND, SD, or KS.

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Sales
Branding/Brand Strategy
Marketing
Requirements
  • BA or BS in relevant field; advanced degree preferred. Plus, a minimum 5-7 years of experience in pharma in CNS
  • Minimum 5-7 years of experience in one of the following: product marketing, thought leader engagement, field sales or management
  • 50-70% business travel, by air or car, is regularly required
  • Must live in the territory's geography
  • Demonstrated success and expertise with thought leader engagement, ad boards and speaker’s bureau- strongly preferred
  • Marketing, sales management, and/or extensive pharmaceutical product launch experience- strongly preferred
  • Proven ability to successfully manage accounts in a large geographical territory including both academic and community-based HCPs
  • Demonstrated ability to build productive stakeholder relationships internally and externally with impactful engagement tactics
  • Clinical knowledge and aptitude in complex/competitive disease states, preferably in the CNS market.
  • Strong intellectual curiosity with a desire to continuously learn and improve by applying new knowledge and skills on the job and innovate with market dynamics
  • Highly collaborative with the ability to manage multiple projects simultaneously
  • Self-starter with strong organizational and planning skills. Able to determine effective approaches and take the appropriate action based on the available information/resources consistent with the over-arching strategy
  • Effective verbal and written communication skills
Responsibilities
  • Function as a thought leader liaison to key KOLs within the community and build bridge to/from customer to Axsome Therapeutics
  • Develop and maintain KOL engagement plans and influence maps for thought leaders
  • Engage with KOLs at local, regional, and national congresses and advocacy events to discuss brand, disease state and commercial strategy as well as facilitate engagements and opportunities for executive leadership in support of marketing initiatives
  • Gather insights from key thought leaders to inform brand strategy and support development of content, tactics, and resources, when appropriate
  • Support cross-functional teams to gather key customer insights and input on the marketplace by garnering insights on commercial strategy, including designing local marketplace tactics, clinical messaging, access, and educational needs.
  • Supporting the execution of approved Commercial Advisory Boards
  • Assist in identification of Healthcare Professional (HCP) consultants based on profile established by the approved Consultant Engagement Project Brief
  • Design, Facilitate, participate in, and attend advisory boards, where appropriate
  • Identify and develop HCP and access speakers to provide compliant, high-quality speaker programs on disease state, mechanism of disease, and product, when appropriate
  • Ensure appropriate and compliant execution of speaker programs
  • Monitor speaker performance at events and develops speakers to provide high quality promotional education through coaching as needed
  • Work with Marketing and contracted speakers to gain and synthesize feedback on current and future content development
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
  • Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
  • Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

What critics are saying

  • Increased competition from companies like Compass Pathways in the CNS market.
  • Potential delays in AXS-07 launch amid growing market anticipation.
  • Departure of key personnel like Lori Englebert may impact strategic direction.

What makes Axsome Therapeutics Inc unique

  • Axsome focuses on CNS disorders with limited current treatment options.
  • AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
  • Axsome's balanced portfolio includes both clinical and research stage products.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company Equity

INACTIVE